Roche Wins FDA Approval for Gazyva in Primary Membranous Nephropathy
The FDA approved Gazyva/Gazyvaro (obinutuzumab) for adults with primary membranous nephropathy, Roche says.
The FDA approved Gazyva/Gazyvaro (obinutuzumab) for adults with primary membranous nephropathy, Roche says.